Sold as Tenoretic 100, Tenoretic 50. Every FDA application for this active ingredient: 1 branded and 9 generic. Boxed warning
As of Nov 22, 2026, FDA lists 10 applications for Atenolol; Chlorthalidone (sold as Tenoretic 100, Tenoretic 50), first approved Jun 8, 1984, with 0 new uses approved and 0 published complete response letters.
| Jun 8, 1984 | Tenoretic 100, Tenoretic 50NDA 18760 · New combination | TWi Pharmaceuticals | 29 | Discontinued |
| May 31, 1990 | Atenolol and ChlorthalidoneANDA 72302 | Aiping Pharmaceutical | 12 | Marketed |
| Jul 2, 1992 | Atenolol and ChlorthalidoneANDA 73665 | Watson Laboratories | 17 | Marketed |
| Apr 29, 1993 | Atenolol and ChlorthalidoneANDA 73582 | Sun Pharmaceutical Industries | 23 | Discontinued |
| Oct 31, 1993 | Atenolol and ChlorthalidoneANDA 74203 | Aurobindo Pharma USA | 13 | Discontinued |
| Sep 24, 1997 | Atenolol and ChlorthalidoneANDA 74107 | PLIVA | 3 | Discontinued |
| May 14, 1998 | Atenolol and ChlorthalidoneANDA 74404 | Nostrum Laboratories | 1 | Discontinued |
| Mar 8, 2019 | Atenolol and ChlorthalidoneANDA 210028 | Zydus Pharmaceuticals (USA) | 1 | Marketed |
| Nov 25, 2020 | Atenolol and ChlorthalidoneANDA 213302 | Unichem Laboratories | 1 | Marketed |
| Oct 25, 2021 | Atenolol and ChlorthalidoneANDA 215560 | Novitium Pharma | 1 | Marketed |
| Atenolol-Chlorthalidone | Part D | $8.5M | −7% | 84,354 |
| Tenoretic 50 | Part D | $0 | −100% | 0 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA